108 related articles for article (PubMed ID: 16445570)
1. Effects of trans-resveratrol on hypertension-induced cardiac hypertrophy using the partially nephrectomized rat model.
Liu Z; Song Y; Zhang X; Liu Z; Zhang W; Mao W; Wang W; Cui W; Zhang X; Jia X; Li N; Han C; Liu C
Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1049-54. PubMed ID: 16445570
[TBL] [Abstract][Full Text] [Related]
2. [Preventive effect of trans-resveratrol on hypertension-induced cardiac hypertrophy in partially nephrectomized rats].
Liu ZP; Song Y; Liu ZQ; Zhang XP
Wei Sheng Yan Jiu; 2005 Nov; 34(6):756-8. PubMed ID: 16535856
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol induces mitochondrial biogenesis and ameliorates Ang II-induced cardiac remodeling in transgenic rats harboring human renin and angiotensinogen genes.
Biala A; Tauriainen E; Siltanen A; Shi J; Merasto S; Louhelainen M; Martonen E; Finckenberg P; Muller DN; Mervaala E
Blood Press; 2010 Jun; 19(3):196-205. PubMed ID: 20429690
[TBL] [Abstract][Full Text] [Related]
4. Possible role of nitric oxide in the protective effect of resveratrol in 5/6th nephrectomized rats.
Chander V; Chopra K
J Surg Res; 2006 Jun; 133(2):129-35. PubMed ID: 16325855
[TBL] [Abstract][Full Text] [Related]
5. Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats.
Zolk O; Flesch M; Schnabel P; Teisman AC; Pinto YM; van Gilst WH; Paul M; Böhm M
Br J Pharmacol; 1998 Feb; 123(3):405-12. PubMed ID: 9504380
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II induced upregulation of G alpha q/11, phospholipase C beta 3 and extracellular signal-regulated kinase 1/2 via angiotensin II type 1 receptor.
Bai H; Wu LL; Xing DQ; Liu J; Zhao YL
Chin Med J (Engl); 2004 Jan; 117(1):88-93. PubMed ID: 14733781
[TBL] [Abstract][Full Text] [Related]
7. EGCG inhibits proliferation of cardiac fibroblasts in rats with cardiac hypertrophy.
Sheng R; Gu ZL; Xie ML; Zhou WX; Guo CY
Planta Med; 2009 Feb; 75(2):113-20. PubMed ID: 19096994
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.
Li H; Shi S; Sun YH; Zhao YJ; Li QF; Li HZ; Wang R; Xu CQ
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):312-8. PubMed ID: 18986329
[TBL] [Abstract][Full Text] [Related]
9. Influence of specific and non-specific endothelin receptor antagonists on renal morphology in rats with surgical renal ablation.
Nabokov A; Amann K; Wagner J; Gehlen F; Münter K; Ritz E
Nephrol Dial Transplant; 1996 Mar; 11(3):514-20. PubMed ID: 8671823
[TBL] [Abstract][Full Text] [Related]
10. Celecoxib, but not rofecoxib or naproxen, attenuates cardiac hypertrophy and fibrosis induced in vitro by angiotensin and aldosterone.
Wang BH; Bertucci MC; Ma JY; Adrahtas A; Cheung RY; Krum H
Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):912-8. PubMed ID: 20497423
[TBL] [Abstract][Full Text] [Related]
11. Endothelin ETA receptor antagonism does not attenuate angiotensin II-induced cardiac hypertrophy in vivo in rats.
De Smet HR; Menadue MF; Oliver JR; Phillips PA
Clin Exp Pharmacol Physiol; 2003 Apr; 30(4):278-83. PubMed ID: 12680847
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M
Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol inhibits proliferation of cultured rat cardiac fibroblasts: correlated with NO-cGMP signaling pathway.
Wang S; Wang X; Yan J; Xie X; Fan F; Zhou X; Han L; Chen J
Eur J Pharmacol; 2007 Jul; 567(1-2):26-35. PubMed ID: 17499237
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II increases tissue-specific inhibitor of metalloproteinase-2 expression in rat aortic smooth muscle cells in vivo: evidence of a pressure-independent effect.
Castoldi G; di Gioia CR; Travaglini C; Busca G; Redaelli S; Bombardi C; Stella A
Clin Exp Pharmacol Physiol; 2007 Mar; 34(3):205-9. PubMed ID: 17250640
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice.
Dolinsky VW; Chakrabarti S; Pereira TJ; Oka T; Levasseur J; Beker D; Zordoky BN; Morton JS; Nagendran J; Lopaschuk GD; Davidge ST; Dyck JR
Biochim Biophys Acta; 2013 Oct; 1832(10):1723-33. PubMed ID: 23707558
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotective effects of granulocyte colony-stimulating factor in angiotensin II-induced cardiac remodelling.
Jia N; Dong P; Huang Q; Jin W; Zhang J; Dai Q; Liu S
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):262-6. PubMed ID: 18785976
[TBL] [Abstract][Full Text] [Related]
17. Heart remodeling in the hereditary hypertriglyceridemic rat: effect of captopril and nitric oxide deficiency.
Simko F; Luptak I; Matuskova J; Babal P; Pechanova O; Bernatova I; Hulin I
Ann N Y Acad Sci; 2002 Jun; 967():454-62. PubMed ID: 12079874
[TBL] [Abstract][Full Text] [Related]
18. G(alphaq)-protein carboxyl terminus imitation polypeptide GCIP-27 attenuates cardiac hypertrophy in vitro and in vivo.
Zhang HG; Li XH; Zhou JZ; Liu Y; Jia Y; Yuan ZB
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1276-81. PubMed ID: 17973867
[TBL] [Abstract][Full Text] [Related]
19. ET-1 from endothelial cells is required for complete angiotensin II-induced cardiac fibrosis and hypertrophy.
Adiarto S; Heiden S; Vignon-Zellweger N; Nakayama K; Yagi K; Yanagisawa M; Emoto N
Life Sci; 2012 Oct; 91(13-14):651-7. PubMed ID: 22365964
[TBL] [Abstract][Full Text] [Related]
20. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S; Long CL; Wang RH; Wang H
Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
